{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":32,"n_cols":5,"rows_kept":32,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[12,2,12,3],[12,4,12,5],[13,2,13,3],[13,4,13,5],[14,2,14,3],[14,4,14,5],[15,2,15,3],[17,2,17,3],[19,2,19,3],[20,2,20,3],[21,2,21,3],[24,2,24,3],[25,2,25,3],[28,2,28,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA990005832300403321"]
[null,null,"Autore",null,"Trench, Richard Chenevix <1807-1886>"]
[null,null,"Titolo",null,"On the study of words / Richard Chenevix Trench ; with a new introduction by Roy Harris"]
[null,null,"Pubbl/distr/stampa",null,"London : Routledge, 1994 : Thoemmes Press"]
[null,null,"ISBN",null,"0415092590"]
[null,null,"Edizione",null,"[Repr. of ed.: London, 1851]"]
[null,null,"Descrizione fisica",null,"XI, 216 p. ; 24 cm , In cofanetto"]
[null,null,"Locazione",null,"FLFBC"]
[null,null,"Collocazione",null,"420 HOL 1 (6)"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,"2.","Record Nr.",null,"UNINA9910556878103321"]
[null,null,"Autore",null,"Weiss Jeffrey N."]
[null,null,"Titolo",null,"Stem cell surgery trials in heart failure and diabetes : a concise guide / / Jeffrey N. Weiss"]
[null,null,"Pubbl/distr/stampa",null,"Cham, Switzerland : , : Springer, , [2022]"]
[{"$nulls":4},"©2022"]
[null,null,"ISBN",null,"9783030780104"]
[{"$nulls":4},"9783030780098"]
[null,null,"Descrizione fisica",null,"1 online resource (164 pages)"]
[null,null,"Disciplina",null,"616.46206"]
[null,null,"Soggetti",null,"Diabetes - Treatment"]
[{"$nulls":4},"Stem cells - Transplantation"]
[{"$nulls":4},"Heart failure - Treatment"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Includes index."]
[null,null,"Nota di contenuto",null,"Intro -- Preface -- Contents -- Part I: Heart Failure (United States) -- Chapter 1: Bone Marrow-Derived Mesenchymal Stem Cells in Improving Heart Function in Patients with Heart Failure Caused by Anthracyclines -- Chapter 2: Donor Bone Marrow-Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients with Cardiomyopathy Caused by Anthracyclines -- Chapter 3: The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial -- Chapter 4: Regression of Fibrosis and Reversal of Diastolic Dysfunction in HFPEF Patients Treated with Allogeneic CDCs -- Chapter 5: Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure -- Part II: Heart Failure (Europe) -- Chapter 6: Allogeneic Stem Cell Therapy in Heart Failure -- Chapter 7: Stem Cell Therapy in Advanced Heart Failure -- Chapter 8: Stem Cell Therapy in Ischemic Non-treatable Cardiac Disease -- Chapter 9: Infusion Intracoronary of Mononuclear Autologous Adult Non Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients with Idiopathic Dilated Cardiomyopathy and Heart Failure -- Chapter 10: Cell Therapy in HFpEF -- Chapter 11: Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-Derived Mononuclear Cells on Mortality in Patients with Chronic Post-infarction Heart Failure -- Chapter 12: Impact of Intracoronary Injection "]
[{"$nulls":4},"of Autologous BMMC for LV Contractility and Remodeling in Patients with STEMI -- Chapter 13: Stem Cell Therapy in Non-ischemic, Non-treatable Dilated Cardiomyopathies II: A Pilot Study -- Part III: Heart Failure (Iran) -- Chapter 14: IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients -- Chapter 15: ICMNC-HF: IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients."]
[{"$nulls":4},"Part IV: Heart Failure (China) -- Chapter 16: Treating Heart Failure with hPSC-CMs -- Part V: Diabetes Mellitus: Type 1 Diabetes (United States) -- Chapter 17: Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells -- Chapter 18: A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes -- Chapter 19: Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes -- Chapter 20: Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease -- Part VI: Diabetes Mellitus: Type 1 Diabetes (China) -- Chapter 21: Stem Cell Educator Therapy in Diabetes -- Chapter 22: Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy -- Part VII: Diabetes Mellitus: Type 1 Diabetes (China/Spain) -- Chapter 23: Stem Cell Educator Therapy in Type 1 Diabetes -- Part VIII: Diabetes Mellitus: Type 1 Diabetes (South America) -- Chapter 24: Mesenchymal Stem Cells in Patients with Type 1 Diabetes Mellitus -- Part IX: Diabetes Mellitus: Type 1 Diabetes (Canada) -- Chapter 25: Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM) -- Part X: Diabetes Mellitus: Type 1 Diabetes (Middle East) -- Chapter 26: Mesenchymal Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Patients (MSCTXT1DM) -- Chapter 27: Use of Stem Cells in Diabetes Mellitus Type 1 -- Part XI: Diabetes Mellitus: Type 1 Diabetes (Sweden) -- Chapter 28: Wharton's Jelly-Derived Mesenchymal Stromal Cell-Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes -- Part XII: Diabetes Mellitus: Type 2 Diabetes (United States) -- Chapter 29: Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial Dysfunction in Diabetic Subjects (ACESO) -- Chapter 30: Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease -- Part XIII: Diabetes Mellitus: Type 2 Diabetes (China)."]
[{"$nulls":4},"Chapter 31: Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus -- Chapter 32: Stem Cell Educator Therapy in Diabetes -- Chapter 33: Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy -- Part XIV: Diabetes Mellitus: Type 2 Diabetes (Near East) -- Chapter 34: BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients -- Part XV: Diabetes Mellitus: Type 2 Diabetes (Vietnam) -- Chapter 35: BM-MNC and UC-MSC Infusion for Type 2 Diabetes Mellitus Patients (T2DM) -- Part XVI: Other Thoughts -- Chapter 36: Conclusion -- References -- Index."]